128 related articles for article (PubMed ID: 27849633)
21. Long-term standard-dose warfarin to prevent thrombosis.
Depenbrock PJ
Am Fam Physician; 2005 Jul; 72(1):36, 41. PubMed ID: 16035681
[No Abstract] [Full Text] [Related]
22. Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin.
Mahtani KR; Nunan D; Heneghan C
Heart; 2015 Nov; 101(21):1689-90. PubMed ID: 26135804
[No Abstract] [Full Text] [Related]
23. "The end of good luck''--long-term survival without anticoagulation: a case report and review of the literature.
Gul EE; Altunbas G; Kayrak M; Ozdemir K
Clin Appl Thromb Hemost; 2012; 18(2):222-4. PubMed ID: 21890569
[TBL] [Abstract][Full Text] [Related]
24. Amiodarone for atrial fibrillation.
Kurnik D; Loebstein R; Olchovsky D
N Engl J Med; 2007 Jun; 356(23):2424-6; author reply 2424-6. PubMed ID: 17561530
[No Abstract] [Full Text] [Related]
25. Elevated international normalized ratio from vitamin K supplement discontinuation.
Miesner AR; Sullivan TS
Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
[TBL] [Abstract][Full Text] [Related]
26. Warfarin therapy for elderly persons with atrial fibrillation.
Wieman HM
Am Fam Physician; 1998 Jul; 58(1):49, 52. PubMed ID: 9672430
[No Abstract] [Full Text] [Related]
27. [Thrice-weekly warfarin administration: results in 12 hemodialysis patients].
Poux JM; Dardim K; Nguyen QT; Arnaud G; Rouby MP; Manescu M
Nephrol Ther; 2013 Nov; 9(6):426-32. PubMed ID: 23830043
[TBL] [Abstract][Full Text] [Related]
28. Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?
Magagnoli M; Castagna L; Masci G; Santoro A
Oncologist; 2004; 9(5):594-5; author reply 596. PubMed ID: 15477645
[No Abstract] [Full Text] [Related]
29. Genetics of warfarin response.
Neville KA; Wicklund BM; Kearns GL
N Engl J Med; 2008 Jun; 358(25):2742. PubMed ID: 18572452
[No Abstract] [Full Text] [Related]
30. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
[TBL] [Abstract][Full Text] [Related]
31. Interaction of duloxetine and warfarin causing severe elevation of international normalized ratio.
Glueck CJ; Khalil Q; Winiarska M; Wang P
JAMA; 2006 Apr; 295(13):1517-8. PubMed ID: 16595756
[No Abstract] [Full Text] [Related]
32. Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin.
Lau YC; Xiong Q; Lip GY; Blann AD
Ann Med; 2016; 48(4):275-81. PubMed ID: 27043881
[TBL] [Abstract][Full Text] [Related]
33. GuidetoCare for patients.
Nurse Pract; 2009 Mar; 34(3):49-50. PubMed ID: 19240638
[No Abstract] [Full Text] [Related]
34. The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin.
Kim JS; Jongnarangsin K; Latchamsetty R; Chugh A; Ghanbari H; Crawford T; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):302-9. PubMed ID: 23443620
[TBL] [Abstract][Full Text] [Related]
35. Critical elevation of international normalized ratio in an elderly woman using a natural health product.
Pottie K; Premji K; Cheskey SL
Can Fam Physician; 2017 Jul; 63(7):536-537. PubMed ID: 28701443
[No Abstract] [Full Text] [Related]
36. Patients with atrial fibrillation often receive improper levels of warfarin.
Mitka M
JAMA; 2008 Oct; 300(14):1640. PubMed ID: 18840828
[No Abstract] [Full Text] [Related]
37. The net clinical benefit of warfarin anticoagulation in atrial fibrillation.
Bussey H
Ann Intern Med; 2010 Feb; 152(4):264-5; author reply 265. PubMed ID: 20157144
[No Abstract] [Full Text] [Related]
38. Apixaban [corrected] and warfarin go head to head in selected adults with venous thromboembolism.
BMJ; 2013 Jul; 347():f4292. PubMed ID: 23824003
[No Abstract] [Full Text] [Related]
39. A case report of a patient carrying CYP2C9*3/4 genotype with extremely low warfarin dose requirement.
Lee SY; Nam MH; Kim JS; Kim JW
J Korean Med Sci; 2007 Jun; 22(3):557-9. PubMed ID: 17596671
[TBL] [Abstract][Full Text] [Related]
40. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.
Naganuma M; Shiga T; Nishikata K; Tsuchiya T; Kasanuki H; Fujii E
J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):363-7. PubMed ID: 11907638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
